Wuhan Hongpeptide Biotechnology Co., Ltd. (Jipei Biological)

Wuhan Hubei Huntide Biotech Co., Ltd.), an innovative manufacturer of small molecule peptides under Jetide Health, is located in Wuhan Optical Valley Biocity and has a production base built according to industrial standards in Xintan Industrial Park, Wuhan Economic Development Zone. The company's team has an average of more than 10 years of experience in the pharmaceutical/biological field. It has built a peptide R&D center of about 800 ㎡ and a cGMP standard multi-function workshop, focusing on the synthesis of small peptides with 2–6 amino acids. The core technologies include liquid phase, solid phase, fragment and enzyme catalytic synthesis (especially liquid phase synthesis), and provide modification services such as C-terminal/N-terminal modification, disulfide bond/amide cyclization. Products range from polypeptide building blocks, intermediates to active/functional peptides and peptide derivatives (such as carnosine L-Carnosine, glutamine dipeptide, N-acetyl carnosine, Gly-His-Lys skin care peptide, etc.), and provide process development, custom synthesis, and OEM foundry (laboratory/pilot to commercial scale) for customers in the pharmaceutical, cosmetic, and food sectors. The parent company Jipeptide Biotechnology (founded in Wuhan in September 2012) has 200 acres of chemical land, 20,000 square meters of self-built plant, 4 industrialized production lines, and an annual production capacity of 1,000 tons of small molecule peptides, fully implementing GMP management.

R&D centre: Wuhanguanggushengwucheng, China.

Wuhan Hongpeptide Biotechnology Co., Ltd. (Jipei Biological) is located at Wuhan Economic and Technological Development Zone Xintanxinqujinghan Avenue, China.

Production base: Wuhanjingkaixintangongjianqu, China.

Main peptides produced: GHK-Cu, Full range / custom synthesis.

Finished peptide dosage forms available.

Website: https://www.huntide.com